Antibody-Secreting Cells To Diagnose Mycobacterium tuberculosis Infection in Children in Pakistan

Reliance on microbiologic methods to diagnose infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of ped...

Full description

Saved in:
Bibliographic Details
Published in:mSphere Vol. 5; no. 1
Main Authors: Iqbal, Najeeha Talat, Ahmed, Kumail, Qamar, Farah N, Shaheen, Fariha, Mehnaz, Aisha, Arif, Fehmina, Saeed, Amna Afzal, Yousuf, Aneeq Muhammad, Raza, Syeda Fatima, Sultana, Shazia, Qureshi, Shahida Mumtaz, Siddiqi, Shakil Ahmad, Houpt, Eric, Thomas, Tania
Format: Journal Article
Language:English
Published: United States American Society for Microbiology 05-02-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Reliance on microbiologic methods to diagnose infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of "confirmed TB," "probable TB," or "possible TB." MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively,  < 0.001), and the differences were largely driven by the data from children with confirmed TB (  = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (  = 0.004 and  = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as "culture-confirmed," "probable," and "possible" TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB.
AbstractList ABSTRACT Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P < 0.001), and the differences were largely driven by the data from children with confirmed TB (P = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (P = 0.004 and P = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB.
Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P  < 0.001), and the differences were largely driven by the data from children with confirmed TB ( P  = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls ( P  = 0.004 and P  = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB.
Reliance on microbiologic methods to diagnose infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of "confirmed TB," "probable TB," or "possible TB." MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively,  < 0.001), and the differences were largely driven by the data from children with confirmed TB (  = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (  = 0.004 and  = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as "culture-confirmed," "probable," and "possible" TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB.
Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB. ABSTRACT Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P  < 0.001), and the differences were largely driven by the data from children with confirmed TB ( P  = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls ( P  = 0.004 and P  = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort. IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB.
ABSTRACTReliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A blood-based biomarker assay, such as the mycobacterial-antibody-secreting cell (MASC) assay, could be a major advance for the field of study of pediatric tuberculosis (TB). Children <15 years of age with clinical concern for TB and age-matched children with no concern for TB were enrolled from outpatient clinics in Karachi, Pakistan. MASC, ferritin, and C-reactive protein (CRP) assays were performed, and results were compared among cases and controls, as well as among children with a case definition of “confirmed TB,” “probable TB,” or “possible TB.” MASC responses were significantly higher among children with TB than among controls (0.41 optical density [OD] versus 0.28 OD, respectively, P < 0.001), and the differences were largely driven by the data from children with confirmed TB (P = 0.002). Ferritin and CRP values were significantly higher among those with confirmed TB than among those with the other disease states and controls (P = 0.004 and P = 0.019, respectively). The use of the MASC assay as a blood-based biomarker for TB disease shows some promise among children with microbiologically confirmed disease; however, the performance characteristics for the majority of young children with unconfirmed TB were suboptimal in this cohort.IMPORTANCE Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully understood due to our limitations with respect to exploring sensitive diagnostic algorithms. In a setting of TB endemicity in Pakistan, we carried out a proof-of-concept study to evaluate for the first time the performance of B cell analyses by the use of well-defined diagnostic criteria and NIH consensus guidelines as “culture-confirmed,” “probable,” and “possible” TB groups. In contrast to detection of serum antibody, we focused on mycobacterial-antibody-secreting cell (MASC) detection as a marker of active disease in children with a strong suspicion of TB. Further work exploring a larger panel of inflammatory biomarkers and enrichment of B cells with the objective of increasing the sensitivity of the current MASC assay would lead to the development of a field-friendly assay for timely diagnosis of childhood TB.
Author Qamar, Farah N
Ahmed, Kumail
Arif, Fehmina
Thomas, Tania
Sultana, Shazia
Houpt, Eric
Raza, Syeda Fatima
Siddiqi, Shakil Ahmad
Shaheen, Fariha
Saeed, Amna Afzal
Qureshi, Shahida Mumtaz
Iqbal, Najeeha Talat
Yousuf, Aneeq Muhammad
Mehnaz, Aisha
Author_xml – sequence: 1
  givenname: Najeeha Talat
  surname: Iqbal
  fullname: Iqbal, Najeeha Talat
  email: najeeha.iqbal@aku.edu
  organization: Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan
– sequence: 2
  givenname: Kumail
  surname: Ahmed
  fullname: Ahmed, Kumail
  organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan
– sequence: 3
  givenname: Farah N
  surname: Qamar
  fullname: Qamar, Farah N
  organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan
– sequence: 4
  givenname: Fariha
  surname: Shaheen
  fullname: Shaheen, Fariha
  organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan
– sequence: 5
  givenname: Aisha
  surname: Mehnaz
  fullname: Mehnaz, Aisha
  organization: Paediatric Ward I, Civil Hospital Karachi, Karachi, Pakistan
– sequence: 6
  givenname: Fehmina
  surname: Arif
  fullname: Arif, Fehmina
  organization: Paediatric Ward I, Civil Hospital Karachi, Karachi, Pakistan
– sequence: 7
  givenname: Amna Afzal
  surname: Saeed
  fullname: Saeed, Amna Afzal
  organization: School of Medicine, Aga Khan University, Karachi, Pakistan
– sequence: 8
  givenname: Aneeq Muhammad
  surname: Yousuf
  fullname: Yousuf, Aneeq Muhammad
  organization: School of Medicine, Aga Khan University, Karachi, Pakistan
– sequence: 9
  givenname: Syeda Fatima
  surname: Raza
  fullname: Raza, Syeda Fatima
  organization: School of Medicine, Aga Khan University, Karachi, Pakistan
– sequence: 10
  givenname: Shazia
  surname: Sultana
  fullname: Sultana, Shazia
  organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan
– sequence: 11
  givenname: Shahida Mumtaz
  surname: Qureshi
  fullname: Qureshi, Shahida Mumtaz
  organization: Department of Paediatrics, Aga Khan University, Karachi, Pakistan
– sequence: 12
  givenname: Shakil Ahmad
  surname: Siddiqi
  fullname: Siddiqi, Shakil Ahmad
  organization: Sindh Government Hospital Korangi, Karachi, Pakistan
– sequence: 13
  givenname: Eric
  surname: Houpt
  fullname: Houpt, Eric
  organization: Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA
– sequence: 14
  givenname: Tania
  surname: Thomas
  fullname: Thomas, Tania
  organization: Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32024709$$D View this record in MEDLINE/PubMed
BookMark eNpdkstvEzEQxi1UREvonRNaiQuXLX7s-nFBqsIrUhFILWfLa88mDrt2sL1I-e_ZJqFqOXlkf_Ob8cz3Ep2FGACh1wRfEULl-_F2t4EEVxhzRmuinqELyoSqW9zQs0fxObrMeYsxJpxyLvgLdM4opo3A6gKZ61B8F92-vgWboPiwrpYwDLm6i9VHb9YhZqi-7W3sjC2Q_DRWZeog2WmI2edqFXqwxcdQ-VAtN35wCQ7xD_PL52LCK_S8N0OGy9O5QD8_f7pbfq1vvn9ZLa9vatsoXGopeulaZ5ghQlDJjLHSqq6XqhXCEi4aAkwJhokFS6lylEDPJfSkl63rGrZAqyPXRbPVu-RHk_Y6Gq8PFzGttUnF2wG0ctZQ00KHOWmEPZThDSg-88VMnlkfjqzd1I3gLISSzPAE-vQl-I1exz9aYEzZvI8FencCpPh7glz06LOd52oCxClrylqKW8Kb-77f_ifdximFeVSzikuuiGrxrMJHlU0x5wT9QzME63s76JMd9MEOmqg55c3jTzwk_Fs--wsSKrSk
CitedBy_id crossref_primary_10_2147_IDR_S295798
crossref_primary_10_1155_2020_8235149
Cites_doi 10.1128/CVI.00501-12
10.5588/ijtld.15.0471
10.1371/journal.pone.0169118
10.1371/journal.pone.0064226
10.3389/fimmu.2019.01317
10.1136/thoraxjnl-2012-201817
10.1128/JCM.26.11.2313-2318.1988
10.1136/thoraxjnl-2015-207999
10.1111/imm.13023
10.1086/376511
10.1179/2046905512Y.0000000008
10.1371/journal.pone.0016425
10.1371/journal.pmed.1001012
10.1371/journal.pone.0126863
10.18632/oncotarget.11420
10.1093/infdis/jis008
10.1128/CVI.00391-08
10.1186/1472-6963-11-187
10.4103/2320-8775.126504
10.1016/j.cyto.2019.154773
10.1128/CDLI.11.6.1022-1027.2004
10.1136/thx.2010.147363
10.1016/s0022-3476(97)70200-2
10.1371/journal.pone.0097992
10.1128/CDLI.2.6.726-732.1995
10.1182/blood-2004-07-2507
10.1088/1752-7163/11/1/016003
10.1093/cid/civ613
10.1093/cid/ciu945
ContentType Journal Article
Copyright Copyright © 2020 Iqbal et al.
Copyright © 2020 Iqbal et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2020 Iqbal et al. 2020 Iqbal et al.
Copyright_xml – notice: Copyright © 2020 Iqbal et al.
– notice: Copyright © 2020 Iqbal et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2020 Iqbal et al. 2020 Iqbal et al.
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1128/mSphere.00632-19
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

PubMed
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Immune Biomarkers of Pediatric TB
EISSN 2379-5042
Editor Achkar, Jacqueline M.
Editor_xml – sequence: 1
  givenname: Jacqueline M.
  surname: Achkar
  fullname: Achkar, Jacqueline M.
ExternalDocumentID oai_doaj_org_article_9dca2a5eb06147cc9bf864e9697379d2
10_1128_mSphere_00632_19
32024709
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Bangladesh
Pakistan
GeographicLocations_xml – name: Pakistan
– name: Bangladesh
GrantInformation_xml – fundername: ;
  grantid: 51543
GroupedDBID 0R~
3V.
53G
5VS
7X7
8FE
8FH
8FI
8FJ
AAFWJ
AAUOK
ABUWG
ADBBV
AFKRA
AFPKN
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
DIK
EBS
FRP
FYUFA
GROUPED_DOAJ
H13
HCIFZ
HMCUK
HYE
KQ8
LK8
M48
M7P
M~E
NPM
O9-
OK1
PGMZT
PIMPY
PQQKQ
PROAC
R9-
RHF
RHI
RPM
RSF
UKHRP
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c490t-87f8d5da3a177283aac8c9bf89577c16741e397301cec229d21ef68ef1f85db43
IEDL.DBID RPM
ISSN 2379-5042
IngestDate Tue Oct 22 15:14:24 EDT 2024
Tue Sep 17 21:31:08 EDT 2024
Fri Oct 25 05:17:37 EDT 2024
Sat Nov 09 15:49:11 EST 2024
Fri Aug 23 01:13:04 EDT 2024
Sat Sep 28 08:30:07 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords antibody-secreting cells
biomarkers
tuberculosis
Language English
License Copyright © 2020 Iqbal et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c490t-87f8d5da3a177283aac8c9bf89577c16741e397301cec229d21ef68ef1f85db43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Iqbal NT, Ahmed K, Qamar FN, Shaheen F, Mehnaz A, Arif F, Saeed AA, Yousuf AM, Raza SF, Sultana S, Qureshi SM, Siddiqi SA, Houpt E, Thomas T. 2020. Antibody-secreting cells to diagnose Mycobacterium tuberculosis infection in children in Pakistan. mSphere 5:e00632-19. https://doi.org/10.1128/mSphere.00632-19.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002306/
PMID 32024709
PQID 2368691950
PQPubID 2045592
ParticipantIDs doaj_primary_oai_doaj_org_article_9dca2a5eb06147cc9bf864e9697379d2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7002306
proquest_miscellaneous_2352051644
proquest_journals_2368691950
crossref_primary_10_1128_mSphere_00632_19
pubmed_primary_32024709
PublicationCentury 2000
PublicationDate 20200205
PublicationDateYYYYMMDD 2020-02-05
PublicationDate_xml – month: 2
  year: 2020
  text: 20200205
  day: 5
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
– name: 1752 N St., N.W., Washington, DC
PublicationTitle mSphere
PublicationTitleAlternate mSphere
PublicationYear 2020
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_20_2
WHO (e_1_3_2_12_2) 2014
e_1_3_2_21_2
e_1_3_2_23_2
e_1_3_2_24_2
Mehnaz A (e_1_3_2_22_2) 2006; 56
e_1_3_2_25_2
Naher N (e_1_3_2_29_2) 2015; 24
WHO (e_1_3_2_38_2) 2016
e_1_3_2_9_2
e_1_3_2_15_2
WHO (e_1_3_2_2_2) 2018
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
Lewinsohn DA (e_1_3_2_18_2) 2004; 8
e_1_3_2_4_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_14_2
e_1_3_2_35_2
National TB Control Programme, Federal Ministry of Health (e_1_3_2_34_2) 2006
References_xml – volume: 8
  start-page: 658
  year: 2004
  ident: e_1_3_2_18_2
  article-title: Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities
  publication-title: Int J Tuber Lung Dis
  contributor:
    fullname: Lewinsohn DA
– ident: e_1_3_2_20_2
  doi: 10.1128/CVI.00501-12
– ident: e_1_3_2_3_2
  doi: 10.5588/ijtld.15.0471
– ident: e_1_3_2_8_2
  doi: 10.1371/journal.pone.0169118
– ident: e_1_3_2_11_2
  doi: 10.1371/journal.pone.0064226
– ident: e_1_3_2_19_2
  doi: 10.3389/fimmu.2019.01317
– ident: e_1_3_2_7_2
  doi: 10.1136/thoraxjnl-2012-201817
– ident: e_1_3_2_17_2
  doi: 10.1128/JCM.26.11.2313-2318.1988
– ident: e_1_3_2_25_2
  doi: 10.1136/thoraxjnl-2015-207999
– ident: e_1_3_2_23_2
– volume: 24
  start-page: 756
  year: 2015
  ident: e_1_3_2_29_2
  article-title: Serum C-reactive protein (CRP) level in tuberculous patients
  publication-title: Mymensingh Med J
  contributor:
    fullname: Naher N
– ident: e_1_3_2_30_2
  doi: 10.1111/imm.13023
– ident: e_1_3_2_5_2
  doi: 10.1086/376511
– volume-title: Global tuberculosis report 2018
  year: 2018
  ident: e_1_3_2_2_2
  contributor:
    fullname: WHO
– ident: e_1_3_2_33_2
  doi: 10.1179/2046905512Y.0000000008
– ident: e_1_3_2_6_2
  doi: 10.1371/journal.pone.0016425
– ident: e_1_3_2_15_2
  doi: 10.1371/journal.pmed.1001012
– ident: e_1_3_2_10_2
  doi: 10.1371/journal.pone.0126863
– volume-title: The WHO child growth standards
  year: 2016
  ident: e_1_3_2_38_2
  contributor:
    fullname: WHO
– ident: e_1_3_2_26_2
  doi: 10.18632/oncotarget.11420
– ident: e_1_3_2_37_2
  doi: 10.1093/infdis/jis008
– ident: e_1_3_2_9_2
  doi: 10.1128/CVI.00391-08
– volume-title: High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting
  year: 2014
  ident: e_1_3_2_12_2
  contributor:
    fullname: WHO
– ident: e_1_3_2_35_2
  doi: 10.1186/1472-6963-11-187
– ident: e_1_3_2_24_2
  doi: 10.4103/2320-8775.126504
– ident: e_1_3_2_27_2
  doi: 10.1016/j.cyto.2019.154773
– ident: e_1_3_2_14_2
  doi: 10.1128/CDLI.11.6.1022-1027.2004
– ident: e_1_3_2_13_2
  doi: 10.1136/thx.2010.147363
– ident: e_1_3_2_21_2
  doi: 10.1016/s0022-3476(97)70200-2
– volume: 56
  start-page: 390
  year: 2006
  ident: e_1_3_2_22_2
  article-title: Tuberculosis in children
  publication-title: J Pak Med Assoc
  contributor:
    fullname: Mehnaz A
– ident: e_1_3_2_31_2
  doi: 10.1371/journal.pone.0097992
– ident: e_1_3_2_36_2
  doi: 10.1128/CDLI.2.6.726-732.1995
– ident: e_1_3_2_16_2
  doi: 10.1182/blood-2004-07-2507
– ident: e_1_3_2_28_2
  doi: 10.1088/1752-7163/11/1/016003
– ident: e_1_3_2_4_2
  doi: 10.1093/cid/civ613
– volume-title: National guidelines for diagnosis and management of tuberculosis in children NTP Pakistan
  year: 2006
  ident: e_1_3_2_34_2
  contributor:
    fullname: National TB Control Programme, Federal Ministry of Health
– ident: e_1_3_2_32_2
  doi: 10.1093/cid/ciu945
SSID ssj0001626676
Score 2.1708236
Snippet Reliance on microbiologic methods to diagnose infection is a suboptimal approach for children due in part to the paucibacillary nature of the disease. A...
Tuberculosis (TB) in children represents a missed opportunity for diagnosis and preventive therapy. The magnitude or burden of disease in children is not fully...
ABSTRACTReliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the...
ABSTRACT Reliance on microbiologic methods to diagnose Mycobacterium tuberculosis infection is a suboptimal approach for children due in part to the...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
SubjectTerms Age
antibody-secreting cells
Antigens
Biomarkers
C-reactive protein
Cell culture
Children
Clinical Science and Epidemiology
Diagnosis
Ferritin
Immunoglobulins
Inflammation
Lymphocytes B
Malnutrition
Mycobacterium tuberculosis
Optical density
Pediatrics
Tuberculosis
Vaccines
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagEhIXBOUVKMhIXDhEXdtJbB_LtlV7KJctEjfLj4lYaZugZnPYf4_HTqNdhMSFWxT7MJnJjL-xx98Q8nkBUDOrdAmBtWVVaVZqJ5EJ03FgguFeP25drOS3H-r8Amly5lZfWBOW6YGz4k518JbbGhymLtJ77VrVVKAbLYXUIUffhdpLptLuSsTpjZzPJbk6vVvhNX3AOi7BSyTW2VuHEl3_3zDmn6WSe2vP5XPybAKN9CwL-4I8gu6YPMltJHcviT3rtmvXh125QhCIhcx0CZvNQG97ep5r6YDe7Hz03cTNPN7R7ejg3o-bflgP9HqqyOrouqPL6Xo3Pk_4sntFvl9e3C6vyql1QukrvdjGGNeqUAcrLIvwWQlrvUqq07WUHm8eMIhIJHq3B8951CODtlHQslbVwVXiNTnq-g7eEtpCAIc8Y1KISjqhHBOu1sI14AXItiBfHhRpfmWGDJMyC67MpHSTlG6YLshX1PQ8D7mt04tocTNZ3PzL4gU5ebCTmRxuMFw0qtHY07Ygn-bh6Cp4_mE76EecU_MYgyICLMibbNZZEmwjX8lFlFAeGPxA1MORbv0z0XHLnMe9-x_f9p485ZjQY1l4fUKOtvcjfCCPhzB-TD_4b1ROAjg
  priority: 102
  providerName: Directory of Open Access Journals
Title Antibody-Secreting Cells To Diagnose Mycobacterium tuberculosis Infection in Children in Pakistan
URI https://www.ncbi.nlm.nih.gov/pubmed/32024709
https://www.proquest.com/docview/2368691950
https://search.proquest.com/docview/2352051644
https://pubmed.ncbi.nlm.nih.gov/PMC7002306
https://doaj.org/article/9dca2a5eb06147cc9bf864e9697379d2
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pa9swFBZLYbDL2Nr9cNcFFXbZwU0l2ZZ07NKWldExSAe7GUt-3gyJXOL4kP9-erIdkrFTb8aW4SE9Sd97-t4nQj5dAqSsUDqGklVxkmgWayNRCdNwYIJhrh9TFwv5_Ze6vkGZnHSshQmkfWvqC7dcXbj6T-BWPq7sbOSJzX7cz2WPnGcTMvHYcC9ED4kVD9EzuTuS5Gq2WmCFPiCFS_CYoVAo3hqeSGQh7u1GQbT_f0jzX8Lk3g50-4q8HKAjvepNfE2egTsmz_vLJLcnpLhym9o05TZeIBREOjOdw3LZ0oeGXveMOqD3W-tncFBo7lZ00xlY227ZtHVL7wZelqO1o_OhyBufB5Tp3pCftzcP86_xcIFCbBN9ufErXaXKtCxEwTyIVqIorLLaVEqnUlqsP2Dg8Yif4xYs57rkDKpMQcUqlZYmEW_JkWscvCe0ghIMqo1JIRJphDJMmFQLk4EVIKuIfB47Mn_sdTLyEF9wlQ_9n4f-z5mOyBfs6V07VLgOL5r173wY51yXtuBFCgZDVmmD2VkCOvP2Sm9pRM7GccqHadfmXGQq03izbUTOd5_9hMFTkMJB02GblPuVyOPAiLzrh3VnyegWEZEHA35g6uEX76NBlHvwydMn__mBvOAYyyMjPD0jR5t1Bx_JpC27qYf6d9-mIV0wDc7-FwMxBDs
link.rule.ids 230,315,729,782,786,866,887,2108,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLbYEILL-M0CA4LEhUPW2k5i-zi6TZtYJ6QWiZsVOy8jUptMTXPof4-fk1Qt4rRbFDvSU9579mf7e58J-ToGSGgmVQQ5LaI4VjRSRqASpmFAOcW9fty6mInb3_L8AmVykqEWxpP2rSlPq8XytCr_eG7l_dKOBp7Y6Od0IjrkPDogj12-jvnOIt1vrTiQnortoSSTo-UMa_QBSVycRRSlQvHe8FggD3FnPvKy_f_Dmv9SJnfmoMvnD7T-BTnqQWd41jW_JI-gekWedNdQbl6T7Kxal6bON9EMQSQSocMJLBZNOK_D846LB-F0Y13ue23ndhmuWwMr2y7qpmzC657RVYVlFU768nB87vFp9Yb8uryYT66i_uqFyMZqvHZjZCHzJM94Rh38ljzLrLTKFFIlQlisXKDgkIwbHSxYxlTOKBSphIIWMslNzN-Sw6qu4JiEBeRgUKdMcB4Lw6Wh3CSKmxQsB1EE5NvgAH3fKWxovzJhUvd-095vmqqAfEcPbfuhNrZ_Ua_udP-PtcptxrIEDC52hfVmpzGo1NkrnKUBORn8q_uEbTTjqUwV3okbkC_bZpdqeH6SVVC32CdhbgxzCDIg77pw2FoyhFNAxF6g7Jm63-Liw8t59_Hw_sFffiZPr-bTG31zffvjA3nGcEcAeeXJCTlcr1r4SA6avP3kk-QvlHoXyg
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwFLbYEGgXfsMCA4LEhUOW2k5i-zjaVUywaVKHxM2KnReI1CZV0xz63-PnpFWLOMEtShzpJe_Z_vz8-XuEfBwBpDSXKoKCllGSKBopI1AJ0zCgnGKuH1MXM3HzQ04uUSZnV-rLk_atqc7r-eK8rn55buVyYeMtTyy-vR6LHjnHy6KMj8h912dH6d5C3adXHFDPxG5jksl4McNz-oBELs4iinKhWDs8EchF3JuTvHT_3_Dmn7TJvXlo-vg_vuAJeTSAz_Cib_KU3IP6GXnQl6PcPCf5Rb2uTFNsohmCSSREh2OYz9vwrgknPScPwuuNdWOA13juFuG6M7Cy3bxpqza8GphddVjV4Xg4Jo7XA06tX5Dv08u78ZdoKMEQ2USN1m6sLGWRFjnPqYPhkue5lVaZUqpUCIsnGCg4RONGCQuWMVUwCmUmoaSlTAuT8JfkuG5qOCVhCQUY1CsTnCfCcGkoN6niJgPLQZQB-bR1gl72Shvar1CY1IPvtPedpiogn9FLu3aoke1vNKufevjPWhU2Z3kKBhe9wnqzswRU5uwVztKAnG19rIeO22rGM5kprI0bkA-7x67L4T5KXkPTYZuUubHMIcmAvOpDYmfJNqQCIg6C5cDUwycuRrys9xATr__5zffk4e1kqr9d3Xx9Q04YJgaQXp6ekeP1qoO35Kgtune-n_wGTxgaSg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibody-Secreting+Cells+To+Diagnose+Mycobacterium+tuberculosis+Infection+in+Children+in+Pakistan&rft.jtitle=mSphere&rft.au=Iqbal%2C+Najeeha+Talat&rft.au=Kumail%2C+Ahmed&rft.au=Qamar%2C+Farah+N&rft.au=Shaheen+Fariha&rft.date=2020-02-05&rft.pub=American+Society+for+Microbiology&rft.eissn=2379-5042&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1128%2FmSphere.00632-19&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-5042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-5042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-5042&client=summon